Impact Evaluation of Benazir Nashonuma Program (BNP) on Stunting Among Under-five Children
Launched by AGA KHAN UNIVERSITY · Aug 30, 2023
Trial Information
Current as of April 25, 2025
Recruiting
Keywords
ClinConnect Summary
The Benazir Nashonuma Program (BNP) study is looking at how this program affects stunting, which is when children don’t grow tall enough for their age, among kids under five years old in certain areas of Pakistan. The researchers want to find out if children in areas with BNP have less stunting compared to those in areas without this program. They will compare the growth and nutrition of children in both groups over four years.
To take part in this study, families need to have a child under five years old and a mother who is registered with the Benazir Income Support Program. It's important that both the mother and child are available for interviews. The study is open to all genders and aims to help understand how programs like BNP can improve child health in low-income settings. Participants can expect to provide information about their child’s growth and nutrition, helping to shape future health initiatives.
Gender
ALL
Eligibility criteria
- All those households are eligible to be included in the study who have:
- • An under-five child with a mother registered with Benazir Income Support Program (BISP)
- • Both available at the time of interview
- Exclusion criteria includes:
- • • Mother of the child who is not a woman of reproductive age, i.e., less than 15 years or greater than 49 years
About Aga Khan University
Aga Khan University (AKU) is a distinguished institution dedicated to improving health and education across developing regions. Established in 1983, AKU is recognized for its commitment to research excellence, particularly in clinical trials that address pressing health issues in diverse populations. With a focus on advancing medical knowledge and practice, AKU's clinical trial initiatives are designed to foster innovative solutions and enhance patient care. The university collaborates with various local and international partners, leveraging its multidisciplinary expertise to conduct rigorous research that informs public health policy and improves health outcomes in communities served by its facilities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, Sindh, Pakistan
Patients applied
Trial Officials
Zulfiqar A Bhutta, PhD, FRC
Principal Investigator
Aga Khan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported